Related Experiment Video
Updated: Aug 14, 2026

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings
Erik D VonKaenel1, Lisa M Bramer1, Javier E Flores1
1Biological Science Division, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
Plos Computational Biology
|August 12, 2026
Summary
This study evaluates sure screening methods for feature selection in high-dimensional omics data. BcorSIS demonstrated superior effectiveness and computational efficiency compared to other methods like CSIS and DCSIS.
Area of Science:
- Bioinformatics
- Computational Biology
- Machine Learning
Background:
- High-dimensional omics analyses are increasingly used to study complex biological systems.
- Machine learning (ML) is often employed to identify key biomolecules predictive of biological outcomes.
- Feature selection is critical in ML for omics data due to high dimensionality and limited, unbalanced sample sizes.
Purpose of the Study:
- To evaluate model-free, filter-based feature selection methods using the sure screening principle for omics data.
- To compare the performance and computational efficiency of various sure screening approaches.
- To identify the most effective sure screening method for ML classification in omics applications.
Main Methods:
- The study focused on filter-based feature selection methods grounded in the sure screening principle.
- A suite of model-free sure screening approaches was applied to several omics biomedical datasets.
- Performance was evaluated in a machine learning classification context, comparing runtime and effectiveness.
Main Results:
- BcorSIS was identified as the most effective and computationally efficient sure screening method across diverse omics datasets.
- BcorSIS consistently outperformed other methods, including CSIS and DCSIS, in terms of runtime.
- The study provides a comprehensive evaluation of sure screening for omics data analysis.
Conclusions:
- Sure screening methods offer analytical guarantees for feature set retention in omics data analysis.
- BcorSIS emerges as a highly recommended tool for feature selection in high-dimensional omics data due to its efficiency and effectiveness.
- This work contextualizes feature screening within broader feature selection strategies for omics research.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
